Editorial: Community series in novel insights into immunotherapy targeting tumor microenvironment in ovarian cancer: volume I

• Xiang-jie Di,
• Xiang-jie Di,
• Qi Zhao,
• Hai-tao Wang,
• Xia-wei Wei,
• Xiao Liang

Affiliations

Xiang-jie Di

Key Laboratory of Obstetrics & Gynecologic and Pediatric Diseases and Birth Defects of Ministry of Education, West China Second Hospital, Sichuan University, Chengdu, Sichuan, China

Xiang-jie Di

Laboratory of Aging Research and Cancer Drug Target, State Key Laboratory of Biotherapy and Cancer Center, National Clinical Research Center for Geriatrics, Clinical Trial Center/NMPA Key Laboratory for Clinical Research and Evaluation of Innovative Drug, West China Hospital, Sichuan University, Chengdu, Sichuan, China

Qi Zhao

Ministry of Education (MoE) Frontiers Science Center for Precision Oncology, Cancer Center, Faculty of Health Sciences, University of Macau, Macau, Macau SAR, China

Hai-tao Wang

Thoracic Surgery Branch, Center for Cancer Research, National Cancer Institute (NCI), Bethesda, MD, United States

Xia-wei Wei

Laboratory of Aging Research and Cancer Drug Target, State Key Laboratory of Biotherapy and Cancer Center, National Clinical Research Center for Geriatrics, Clinical Trial Center/NMPA Key Laboratory for Clinical Research and Evaluation of Innovative Drug, West China Hospital, Sichuan University, Chengdu, Sichuan, China

Xiao Liang

Key Laboratory of Obstetrics & Gynecologic and Pediatric Diseases and Birth Defects of Ministry of Education, West China Second Hospital, Sichuan University, Chengdu, Sichuan, China